Clinical trials: Hepatitis C Infection With HIV Co-Infection

Hepatitis C, Chronic, HIV

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

• Completed
• Age: 18 to 64 years
• Phase 4
• Results posted

Response-guided triple-therapy with boceprevir (BOC) in combination with pegylated interferon (PEGIFN) and ribavirin (RBV) is the current standard of care for HIV-negative patients infected with hepatitis C genotype (HCV-GT) 1.

Trial name

HIVCOBOC-RGT (NCT01925183)

Testing

Pegylated interferon alpha-2a, Ribavirin, Boceprevir

Where

Austria

Volunteers

6 people

Sponsor

Markus Peck-Radosavljevic